Cholinergic degeneration and memory loss delayed by vitamin E in a Down syndrome mouse model

Jason Lockrow, Annamalai Prakasam, Peng Huang, Heather Bimonte-Nelson, Kumar Sambamurti, Ann Charlotte Granholm

Research output: Contribution to journalArticle

88 Citations (Scopus)

Abstract

Down syndrome (DS) individuals develop several neuropathological hallmarks seen in Alzheimer's disease, including cognitive decline and the early loss of cholinergic markers in the basal forebrain. These deficits are replicated in the Ts65Dn mouse, which contains a partial trisomy of murine chromosome 16, the orthologous genetic segment to human chromosome 21. Oxidative stress levels are elevated early in DS, and may contribute to the neurodegeneration seen in these individuals. We evaluated oxidative stress in Ts65Dn mice, and assessed the efficacy of long-term antioxidant supplementation on memory and basal forebrain pathology. We report that oxidative stress was elevated in the adult Ts65Dn brain, and that supplementation with the antioxidant vitamin E effectively reduced these markers. Also, Ts65Dn mice receiving vitamin E exhibited improved performance on a spatial working memory task and showed an attenuation of cholinergic neuron pathology in the basal forebrain. This study provides evidence that vitamin E delays onset of cognitive and morphological abnormalities in a mouse model of DS, and may represent a safe and effective treatment early in the progression of DS neuropathology.

Original languageEnglish (US)
Pages (from-to)278-289
Number of pages12
JournalExperimental Neurology
Volume216
Issue number2
DOIs
StatePublished - Apr 2009

Fingerprint

Memory Disorders
Down Syndrome
Vitamin E
Cholinergic Agents
Oxidative Stress
Antioxidants
Pathology
Chromosomes, Human, Pair 21
Cholinergic Neurons
Trisomy
Human Chromosomes
Short-Term Memory
Alzheimer Disease
Brain
Basal Forebrain

Keywords

  • Alpha-tocopherol
  • Alzheimer's disease
  • Basal forebrain cholinergic neuron
  • Calbindin D-28k
  • Neurodegeneration
  • Ts65Dn
  • Working memory

ASJC Scopus subject areas

  • Neurology
  • Developmental Neuroscience

Cite this

Cholinergic degeneration and memory loss delayed by vitamin E in a Down syndrome mouse model. / Lockrow, Jason; Prakasam, Annamalai; Huang, Peng; Bimonte-Nelson, Heather; Sambamurti, Kumar; Granholm, Ann Charlotte.

In: Experimental Neurology, Vol. 216, No. 2, 04.2009, p. 278-289.

Research output: Contribution to journalArticle

Lockrow, Jason ; Prakasam, Annamalai ; Huang, Peng ; Bimonte-Nelson, Heather ; Sambamurti, Kumar ; Granholm, Ann Charlotte. / Cholinergic degeneration and memory loss delayed by vitamin E in a Down syndrome mouse model. In: Experimental Neurology. 2009 ; Vol. 216, No. 2. pp. 278-289.
@article{19b3947732764db0bfccb7f6420f8ce1,
title = "Cholinergic degeneration and memory loss delayed by vitamin E in a Down syndrome mouse model",
abstract = "Down syndrome (DS) individuals develop several neuropathological hallmarks seen in Alzheimer's disease, including cognitive decline and the early loss of cholinergic markers in the basal forebrain. These deficits are replicated in the Ts65Dn mouse, which contains a partial trisomy of murine chromosome 16, the orthologous genetic segment to human chromosome 21. Oxidative stress levels are elevated early in DS, and may contribute to the neurodegeneration seen in these individuals. We evaluated oxidative stress in Ts65Dn mice, and assessed the efficacy of long-term antioxidant supplementation on memory and basal forebrain pathology. We report that oxidative stress was elevated in the adult Ts65Dn brain, and that supplementation with the antioxidant vitamin E effectively reduced these markers. Also, Ts65Dn mice receiving vitamin E exhibited improved performance on a spatial working memory task and showed an attenuation of cholinergic neuron pathology in the basal forebrain. This study provides evidence that vitamin E delays onset of cognitive and morphological abnormalities in a mouse model of DS, and may represent a safe and effective treatment early in the progression of DS neuropathology.",
keywords = "Alpha-tocopherol, Alzheimer's disease, Basal forebrain cholinergic neuron, Calbindin D-28k, Neurodegeneration, Ts65Dn, Working memory",
author = "Jason Lockrow and Annamalai Prakasam and Peng Huang and Heather Bimonte-Nelson and Kumar Sambamurti and Granholm, {Ann Charlotte}",
year = "2009",
month = "4",
doi = "10.1016/j.expneurol.2008.11.021",
language = "English (US)",
volume = "216",
pages = "278--289",
journal = "Experimental Neurology",
issn = "0014-4886",
publisher = "Academic Press Inc.",
number = "2",

}

TY - JOUR

T1 - Cholinergic degeneration and memory loss delayed by vitamin E in a Down syndrome mouse model

AU - Lockrow, Jason

AU - Prakasam, Annamalai

AU - Huang, Peng

AU - Bimonte-Nelson, Heather

AU - Sambamurti, Kumar

AU - Granholm, Ann Charlotte

PY - 2009/4

Y1 - 2009/4

N2 - Down syndrome (DS) individuals develop several neuropathological hallmarks seen in Alzheimer's disease, including cognitive decline and the early loss of cholinergic markers in the basal forebrain. These deficits are replicated in the Ts65Dn mouse, which contains a partial trisomy of murine chromosome 16, the orthologous genetic segment to human chromosome 21. Oxidative stress levels are elevated early in DS, and may contribute to the neurodegeneration seen in these individuals. We evaluated oxidative stress in Ts65Dn mice, and assessed the efficacy of long-term antioxidant supplementation on memory and basal forebrain pathology. We report that oxidative stress was elevated in the adult Ts65Dn brain, and that supplementation with the antioxidant vitamin E effectively reduced these markers. Also, Ts65Dn mice receiving vitamin E exhibited improved performance on a spatial working memory task and showed an attenuation of cholinergic neuron pathology in the basal forebrain. This study provides evidence that vitamin E delays onset of cognitive and morphological abnormalities in a mouse model of DS, and may represent a safe and effective treatment early in the progression of DS neuropathology.

AB - Down syndrome (DS) individuals develop several neuropathological hallmarks seen in Alzheimer's disease, including cognitive decline and the early loss of cholinergic markers in the basal forebrain. These deficits are replicated in the Ts65Dn mouse, which contains a partial trisomy of murine chromosome 16, the orthologous genetic segment to human chromosome 21. Oxidative stress levels are elevated early in DS, and may contribute to the neurodegeneration seen in these individuals. We evaluated oxidative stress in Ts65Dn mice, and assessed the efficacy of long-term antioxidant supplementation on memory and basal forebrain pathology. We report that oxidative stress was elevated in the adult Ts65Dn brain, and that supplementation with the antioxidant vitamin E effectively reduced these markers. Also, Ts65Dn mice receiving vitamin E exhibited improved performance on a spatial working memory task and showed an attenuation of cholinergic neuron pathology in the basal forebrain. This study provides evidence that vitamin E delays onset of cognitive and morphological abnormalities in a mouse model of DS, and may represent a safe and effective treatment early in the progression of DS neuropathology.

KW - Alpha-tocopherol

KW - Alzheimer's disease

KW - Basal forebrain cholinergic neuron

KW - Calbindin D-28k

KW - Neurodegeneration

KW - Ts65Dn

KW - Working memory

UR - http://www.scopus.com/inward/record.url?scp=62049085639&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=62049085639&partnerID=8YFLogxK

U2 - 10.1016/j.expneurol.2008.11.021

DO - 10.1016/j.expneurol.2008.11.021

M3 - Article

C2 - 19135442

AN - SCOPUS:62049085639

VL - 216

SP - 278

EP - 289

JO - Experimental Neurology

JF - Experimental Neurology

SN - 0014-4886

IS - 2

ER -